LATEST ALERTS
Germany agrees on partial recreational cannabis legalisation, after fears that the enforcement of its already approved regulation law would be delayed beyond the 1st April set date
In just a few days, the global cannabis sector will gather again in Barcelona for what has become informally known, for some years now, as the city’s cannabis week
Germany has successfully passed a law legalising the recreational use of cannabis, which could make it the first mainland EU member state to successfully apply a regulatory framework to the sale of recreational cannabis
The Czech government’s newly presented, much-awaited proposal on cannabis regulation falls short of industry expectations, although activists believe there is still room for improving the initial draft
Cannabis rather than hemp will see the primary regulatory changes in 2024, CannIntelligence predicts, with moves coming in the US, Thailand, Germany and France, among others
Optimism over possible regulation of cannabis in Spain has increased as the new ruling coalition has shown some potential for getting back to work on the process
This report aims to briefly analyse the most important legal developments of 2023 related to the EU sustainability proposals that are most likely to impact the CBD vape sector
The election of libertarian Javier Milei is causing as much worry as optimism in Argentina’s cannabis industry, which hopes for a commitment to the continuity of current public policies
While its neighbours Germany and the Czech Republic continue to move closer towards legalising recreational cannabis, Austria appears to be lagging behind. The governing People’s Party is firmly against the idea
This report offers detailed analysis of the current regulatory framework in place in Spain for hemp, CBD and other cannabinoids, as well medical and recreational cannabis
A coalition of centre-right, liberal, and left-wing forces is the most likely to form a new government in Poland before the end of the year, following elections held on 15th October
Partisan gridlock continues to keep Congress from clarifying the regulatory framework for CBD. Even as the Biden administration moves to reschedule cannabis, Congress punts CBD issues back and forth with the FDA
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
